Science Current Events | Science News | Brightsurf.com
 

Wild gorillas carriers of a SIV virus close to the AIDS virus

November 14, 2006

In 2005, 40.3 million people in the world, including 25.8 million in Sub-Saharan Africa, were living with HIV. The question of the origin of HIV-1, responsible for the AIDS pandemic, has been stimulating the scientific community for many years.

Some months ago, the team of Martine Peeters, director of research at IRD, and Eric Delaporte, director of the mixed research unit UMR 145 jointly involving the IRD and the University of Montpellier 1, showed the chimpanzee subspecies living in the Congo Basin (2) to be the reservoir of HIV-1 virus group M, the source of the world pandemic and that of another, very rare variant, HIV-1 group N. However, the reservoir of the third HIV-1 group, group O which infects humans (3), remained unidentified up to now.

This team announces, in an article in the journal Nature, the discovery of a simian immunodeficiency virus (SIV) infection in wild gorillas. Samples of faeces collected from different communities of gorillas found in the remotest areas of the Cameroon tropical forest were found to contain antibodies against this virus, called SIVgor. The genetic characteristics of the virus were present again in three gorillas living more than 400 km apart. Phylogenetic analysis of SIVgor showed it to be related to HIV-1 group O found in humans, essentially in Cameroon and in neighbouring countries.

This discovery of an HIV-1 related virus in wild gorillas does not, however, call into question the fact that chimpanzees are the primary reservoir of SIV/HIV viruses that crop up again in gorillas and in humans. As Martine Peeters of the IRD says, "the viruses of groups M and N are, very clearly, the consequence of inter-species transmission from chimpanzee to humans, whereas the origin of HIV-1 group O is less apparent. It cannot be excluded that chimpanzees infected by HIV-1 group O might have contaminated humans and the gorilla independently, or that the gorilla, having been contaminated by the chimpanzee, might have contaminated humans".

This work thus opens up a Pandora's box on the questions and speculations concerning the ability of these viruses to cross over from one species to another. The main challenges facing these teams for future work will be determination of the prevalence, the geographical distribution and biology of SIV infections in these great apes, not forgetting the question of how the gorillas were contaminated. This last point remains a mystery,considered as rare.

1. UMR 145: Fran Van Heuverswijn, Cecile Neel, Florian Liegeois, Christelle Butel, Eric Delaporte and Martine Peeters jointly involving the IRD and the University of Montpellier1 University of Alabama (Beatrice Hahn and her colleagues), University of Nottingham (Paul Sharp and his colleagues) PRESICA Project of Cameroon headed by Eitel Mpoudi-Ngole.

2. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Mpoudi Ngole E, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH. Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1. Science. 2006 , 313 : 523-6

3. Scientists have known for a long time that the Aids virus shows a very strong genetic variability. Two main types of the virus exist: HIV 1 and HIV 2. HIV 1, the most widely spread in the world, embraces three groups (M, N,O) which manifest different genetic characteristics. Within group M, the most frequent, still 9 further subtypes can be distinguished (A, B, C, D, F, G, H, J, K), genetically close yet distinct.

Institut de Recherche Pour le Développement


Related Hiv-1 Current Events and Hiv-1 News Articles


Pursuing the destruction of HIV-infected cells
An oral drug used to treat an illness unrelated to HIV eradicated infectious HIV-producing cells in lab cultures while sparing uninfected cells - and suppressed the virus in patients during treatment and for at least eight weeks after the drug was stopped, according to results of a clinical pilot trial and researchers at Rutgers University and Dartmouth College.

HIV vaccine design should adapt as HIV virus mutates
Human immunodeficiency virus is known to be a highly variable virus that adapts to a person's immune response during the lifetime infection, and a new study published in Nature Medicine shows that viral adaptation in HIV can predict a person's current disease status, as well as the degree to which newly transmitted HIV-1 is adapted to their new host.

Findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial
Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" antibodies that can prevent HIV infection.

Osel scientists engineer vaginal lactobacillus to express neutralizing HIV-1 antibody fragments
A normal, predominant bacterial species of the healthy vaginal microbiota can be engineered for potential use as a novel protective agent against HIV-1 transmission in women, according to a new publication from scientists at Osel, Inc. and their collaborators.

Temple scientists eliminate HIV-1 from genome of human T-Cells
A specialized gene editing system designed by scientists at the Lewis Katz School of Medicine at Temple University is paving the way to an eventual cure for patients infected with HIV, the virus that causes AIDS.

New research could help improve HIV/AIDS therapies
Hideki Aihara, Zhiqi Yin, and Ke Shi of the University of Minnesota, along with colleagues from Cornell University and St. Louis University have made a major stride in exploring new therapies to combat HIV/AIDS and retrovirus-based cancers.

Progress toward an HIV cure highlighted in special issue of AIDS Research and Human Retroviruses
A cure for HIV/AIDS is the ultimate goal of rapidly advancing research involving diverse and innovative approaches.

Effects on HIV and Ebola
Scientists at the Helmholtz Zentrum München discover that extracts of the medicinal plant Cistus incanus (Ci) prevent human immunodeficiency viruses from infecting cells.

Adenosine deaminase may help the immune system fight HIV on its own
New research findings published in the February 2016 issue of the Journal of Leukocyte Biology, suggest that a new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug.

Neural networks adapt to the presence of a toxic HIV protein
Nearly half of HIV infected patients suffer from impaired neurocognitive function. The HIV protein transactivator of transcription (Tat) is an important contributor to HIV neuropathogenesis because it is a potent neurotoxin that continues to be produced despite treatment with antiretroviral therapy.
More Hiv-1 Current Events and Hiv-1 News Articles

The First Year: HIV: An Essential Guide for the Newly Diagnosed

The First Year: HIV: An Essential Guide for the Newly Diagnosed
by Brett Grodeck (Author), M.D. Daniel S. Berger M.D. (Foreword)


This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans.

The Future of HIV-1 Therapeutics: Resistance Is Futile? (Current Topics in Microbiology and Immunology)

The Future of HIV-1 Therapeutics: Resistance Is Futile? (Current Topics in Microbiology and Immunology)
by Bruce Torbett (Editor), David S. Goodsell (Editor), Douglas Richman (Editor)


This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.

  Advanced Clinical Practice in HIV Care: A Handbook for Nurses, Midwives and other Healthcare Practitioners
by Nathaniel Ault (Editor), Catrin Evans (Editor), Jane Bruton (Editor), Zoe Sheppard (Editor)


As medication and technology has improved, HIV is no longer a terminal illness. It is now considered a long-term condition and nursing is well placed to provide both care and management for people with HIV. This book is the definitive text for nurses working with this patient group at an advanced level, whether in an acute hospital setting, in an HIV or sexual health community setting or alongside other patients with long-term conditions in primary care. Accessible and evidence-based, each chapter in this text is followed by a case study exploring and illustrating the relevant issues as they apply to practice. It is divided into six sections and covers: advanced nursing in HIV sexual health in HIV populations routine care and management dealing with more complex situations ...

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)
by imstilljosh.com


Learning you are HIV-positive is a pretty scary time in a person's life. Josh Robbins found out that he was living with HIV in the beginning of 2012 and started an online journey encouraging others that are living with the virus to keep their mind and spirit in a good place. His main method of offering that encouragement? By sharing images. This coffee-table formatted book shares the images that Josh Robbins of imstilljosh.com uses to fight HIV stigma.

AIDS HIV (ACRN and AACRN) Certification Review (Certification in HIV Nursing Book 1)

AIDS HIV (ACRN and AACRN) Certification Review (Certification in HIV Nursing Book 1)
by Knowledge Testing, Inc.


AIDS Certified Registered Nurse (ACRN) and Advanced AIDS Certified Registered Nurse (AACRN) Certification Review, 600 multiple choice questions.

Provides key information you need to know to pass the board and certification exam.

All questions have explanations with keywords linked to additional online references.

Correct answer is on the next page after the question with explanations and links to further research the key point(s) covered in each question.

Living With HIV: The Essential Guide to Managing and Healing HIV & AIDS Symptoms (HIV essentials, AIDS research, HIV research, HIV test, AIDS virus, HIV ... HIV infection, HIV AIDS, AIDS HIV Book 1)

Living With HIV: The Essential Guide to Managing and Healing HIV & AIDS Symptoms (HIV essentials, AIDS research, HIV research, HIV test, AIDS virus, HIV ... HIV infection, HIV AIDS, AIDS HIV Book 1)


Discover How To Effectively Manage and Heal HIV and AIDS Symptoms So It Can Have A Minimal Impact On Your Life Or The Life Of A Loved One

Today only, get this eBook for just $2.99. Regularly priced at $9.99. Read on your PC, Mac, smart phone, tablet or Kindle device.

Being HIV positive is no longer a death sentence. This book contains proven steps and strategies on how you or a loved one can cope with being diagnosed as HIV positive, as well as the relevant treatments, and frequently asked questions. By properly managing the condition and taking medication correctly, there is no reason why those living with HIV cannot live as normal a life as possible!

HIV is a well-documented, progressive medical condition. When someone becomes infected with HIV and...

Vulnerability, Churches, and HIV: (Church of Sweden Research Series, No. 1)

Vulnerability, Churches, and HIV: (Church of Sweden Research Series, No. 1)
by Goran Gunner (Editor)


The HIV pandemic has caused serious challenges for the Church as well as for theology. The pandemic has brought enormous human suffering to individuals and has affected families and entire societies. In this context, churches need to listen and to learn, and not least to respond, to thereby mold their own actions and futures. In so doing, this book aims to enable churches to become more HIV and AIDS competent. Vulnerability, Churches, and HIV includes two kinds of contributions. First, researchers present their thoughts about theology, the church, and HIV. A pastoral letter from the bishops of the Church of Sweden provides a second perspective. The letter makes recommendations to decision-making bodies, patent holders, and decision makers in the pharmaceutical industry. The letter also...

Encyclopedia of AIDS: A Social, Political, Cultural, and Scientific Record of the HIV Epidemic (1998-08-01)

Encyclopedia of AIDS: A Social, Political, Cultural, and Scientific Record of the HIV Epidemic (1998-08-01)
by unknown (Author)




HIV/AIDS and the Drug Culture: Shattered Lives

HIV/AIDS and the Drug Culture: Shattered Lives
by Joan Gormley (Author), Elizabeth Hagan (Author)


In this startling new collection of case studies entitled HIV/AIDS and the Drug Culture: Shattered Lives, you’ll take an eye-opening and informative look at the lifestyle and culture of the HIV/AIDS intravenous drug users (IVDUs). You’ll see how health care providers and caregivers can update their methods and mindsets in order to meet the needs of this special cross-section of patients.

In each chapter of HIV/AIDS and the Drug Culture, you’ll gain instant access to full medical and psychosocial histories. You’ll also find summaries of important events, clues to recognize, and strategies to safely manage each problematic situation that might arise, all of which will speed you on your way to more effectively and professionally administering to current and former...

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)
by Kuan-Teh Jeang (Editor), J. Thomas August (Editor), Ferid Murad (Editor)


This volume covers the latest advances in the mechanisms of pathogenesis of the HIV-1 virus on target cells. Its companion volume, Advances in Pharmacology 56, shows how new developments in understanding the virus translate to the clinical setting.

© 2016 BrightSurf.com